Navigation Links
Agency Take-up Soars of Agnitio's Leading Pull Marketing Platform for the Healthcare Industry
Date:1/17/2013

COPENHAGEN, Denmark, January 17, 2013 /PRNewswire/ --

  • 50% jump in licences over the last two months
  • Used by leading global agencies

A rapid increase in interest around Agnitio's closed loop marketing platform, has seen the global pharmaceutical marketing company experience a 50% increase in the number of licences granted to advertising, marketing and creative agencies in the last two months alone.

     (Logo: http://photos.prnewswire.com/prnh/20120924/562917-a)
     (Photo: http://photos.prnewswire.com/prnh/20120924/562917-b )

Already used by several of the leading global agencies including Publicis, CDM and Draftfcb, the Agnitio platform has the advantage of being quicker, more flexible and far less resource heavy than other options available. Agencies with rights to the platform can easily create rich content, upload it, share it with their clients and then test it.

"As well as providing the best-in-class pull marketing platform to global healthcare companies directly, we are finding that their agencies are increasingly embracing our platform," says Morten Hjelmsoe, Founder and CEO of Agnitio. "In an ever more competitive healthcare market, the Agnitio platform has the key assets of speed, ease and flexibility to allow pharma companies and their agencies to personalise and optimise interactions with their customers, maximising time and building trusted relationships."

Agnitio licences allow users to create, upload and distribute presentations. They can also facilitate the approval of any new presentation before publishing to the iPad and allow the agency to check that the presentation is generating the correct data in line with its clients' requirements. Based on HTML5, the platform is excellent for localising content and importantly negates the need and desire to produce numerous independent apps, leading to unrelated content which is both costly and difficult to control.

Headquartered in Denmark, with regional hubs in the United States, Latin America and China, Agnitio works for major firms including Bayer, Roche and Takeda, to help generate effective relationships with healthcare professionals via its platform. Through understanding doctors' individual needs and interests, highly relevant and precisely targeted information and services can be provided quickly and easily.

About Agnitio

Agnitio helps pharmaceutical and medical device companies generate effective relationships with medical professionals. The provider of the leading pull marketing software platform for the pharmaceutical and medical device industries, Agnitio's system is already implemented in more than 45 countries and 25 languages - and used by major pharmaceutical and medical device companies including: Takeda, MSD, Amgen, Roche and Bayer.


'/>"/>
SOURCE Agnitio
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
2. UK supplier of graphenes announces exclusive sales agency agreement with leading USA distributor
3. DSP and Takeda Announce the Acceptance of the European Medicines Agency Submission of an Atypical Antipsychotic Agent Lurasidone
4. Awareness of Omega-3 Benefits Soars
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. BioSpace Spotlights Leading Life Science Community
7. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
8. iBioSeminars and iBioMagazine: Free, Online Biology Seminars and Short Talks by Leading Scientists
9. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
10. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
11. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... ... Bacterial biofilms, surface adherent communities of bacteria that are encased in a ... and catheter infections to gum disease and the rejection of medical implants. Though ... year, there is currently a paucity of means for preventing their formation or treating ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... it is exhibiting in booth B2 at the Association for Pathology Informatics ... , In addition to demonstrating its Cancer Diagnostic Cockpit and Consultation Portal, ...
(Date:5/18/2017)... ... May 18, 2017 , ... Dr. ... 2017 at the Prince Of Wales Private Hospital. The procedure was performed on ... The patient failed conservative treatments prior to undergoing surgery. , The AxioMed viscoelastic ...
(Date:5/18/2017)... Massachusetts (PRWEB) , ... May 17, 2017 , ... ... company specializing in medical device compliance and commercialization, has just released version 9.0 ... of work into this latest version of Cockpit,” says David Cronin, CEO of ...
Breaking Biology Technology:
(Date:3/30/2017)... , March 30, 2017 The research team ... for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint ... new realm of speed and accuracy for use in identification, crime ... affordable cost. ... A ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
Breaking Biology News(10 mins):